EAJAIC

The Eurasian Journal of Anesthesiology and Intensive Care (EAJAIC) is an independent-unbiased, peer-reviewed, "double-blind", and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, differential diagnoses, editorial opinions, letters to the editor, and educational papers in anesthesiology, algology, and intensive care medicine.

EndNote Style
Index
Original Article
From anesthesia to healing: the potential of topical sevoflurane in enhancing wound repair
Aims: Sevoflurane is a volatile anesthetic agent commonly used for the induction and maintenance of general anesthesia. Recent case reports and case series have highlighted the analgesic and anti-inflammatory properties of sevoflurane when applied topically to venous ulcers, diabetic wounds, and infected wounds. This study investigates the therapeutic effects of topically applied sevoflurane on thermal burn wounds in rats, focusing on inflammatory responses and wound healing processes.
Methods: Twenty-one male Wistar Albino rats underwent the induction of a second-degree thermal burn covering 3 cm² on the interscapular skin. The animals were randomized into three groups: the experimental group (Group S) received 3 ml of topical sevoflurane (1 ml/cm²), the control group (Group I) received 3 ml of isotonic saline, and the sham group (Group K) received no treatment. Plasma concentrations of TNF-?, IL-1ß, IL-6, and IL-10 were measured at baseline, and on days 7 and 14 post-injury. Histopathological evaluations of the burn sites were conducted on day 14, assessing for active and chronic inflammation, granulation, and fibrosis.
Results: All rats in the study maintained similar age and weight profiles across the groups. Histologically, the sevoflurane group exhibited significantly reduced chronic inflammation and enhanced granulation and fibrosis compared to controls. Immunologically, IL-6 and IL-10 levels were elevated in the isotonic group but did not differ significantly from baseline in other groups. Plasma cytokine levels were comparable across all groups.
Conclusion: Topical sevoflurane appears to promote wound healing by modulating inflammatory responses and enhancing tissue repair processes in a rat burn model. These findings indicate that sevoflurane may serve as a beneficial adjunctive therapy in the management of burn injuries and general wound care. Given its established anti-inflammatory effects when inhaled, there is a compelling need for further research to investigate the potential benefits and mechanisms of topical sevoflurane application. Such studies could provide valuable insights into optimizing wound healing processes and improving patient outcomes.


1. Quintana-Castanedo L, Recarte-Marín L, Pérez-Jerónimo L, Conde-Montero E, de la Cueva-Dobao P. Ulcerative necrobiosis lipoidica diabeticorum successfully treated with topical sevoflurane and punch grafting. Int Wound J. 2019;16(5):1234-1236. doi:10.1111/iwj.13179
2. Rueda-Martínez JL, Gerónimo-Pardo M, Martínez-Monsalve A, Martínez-Serrano M. Topical sevoflurane and healing of a post-operative surgical site superinfected by multi-drug-resistant Pseudomonas aeruginosa and susceptible Staphylococcus aureus in an immunocompromised patient. Surg Infect (Larchmt). 2014;15(6):843-846. doi:10.1089/sur.2013.079
3. Imbernon-Moya A, Ortiz-de Frutos FJ, Sanjuan-Alvarez M, Portero-Sanchez I, Merinero-Palomares R, Alcazar V. Treatment of chronic venous ulcers with topical sevoflurane: a retrospective clinical study. Br J Anaesth. 2017;119(4):846-847. doi:10.1093/bja/aex269
4. Potocnik I, Novak Jankovic V, Šostaric M, et. al. Antiinflammatory effect of sevoflurane in open lung surgery with one-lung ventilation. Croat Med J. 2014;55(6):628-637. doi:10.3325/cmj.2014.55.628
5. Yu X, Zhang F, Shi J. Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities. Immunobiology. 2019;224(5):638-644. doi:10.1016/j.imbio.2019.07.004
6. Yu QB, Li HM, Li LL, Wang SY, Wu YB. Sevoflurane downregulates interleukin-6 and interleukin-8 levels in patients after cardiopulmonary bypass surgery: a meta-analysis. Genet Mol Res. 2015;14(4):19016-19027. doi:10.4238/2015.December.29.9
7. Chhabra S, Chhabra N, Kaur A, Gupta N. Wound healing concepts in clinical practice of OMFS. J Maxillofac Oral Surg. 2017;16(4):403-423. doi: 10.1007/s12663-016-0880-z
8. Imbernón A, Blázquez C, Puebla A, et. al. Chronic venous ulcer treatment with topical sevoflurane. Int Wound J. 2016;13(5):1060-1062. doi:10.1111/iwj.12474
9. Hidalgo-Doniga C, Lopez-Lopez C, Pajero Otero V, et. al. Use of topical sevoflurane in pressure ulcer treatment in a double-lung transplant patient. J Tissue Viability. 2021;30(1):124-127. doi:10.1016/j.jtv.2020.07.003
10. Fernández-Ginés FD, Cortiñas-Sáenz M, Agudo-Ponce D, et. al. Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers. Int Wound J. 2020;17(1):83-90. doi:10.1111/iwj.13235
11. Su L, Zheng J, Wang Y, Zhang W, Hu D. Emerging progress on the mechanism and technology in wound repair. Biomed Pharmacother. 2019; 117:109191. doi:10.1016/j.biopha.2019.109191
12. Dámaso Fernández-Ginés F, Cortiñas-Sáenz M, Mateo-Carrasco H, et. al. Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers. Am J Health Syst Pharm. 2017;74(9):176-182. doi:10.2146/ajhp 151008
13. Cha MS, Lee HJ, Bae JH, Yang WS, Baik SW. Effects of sevoflurane on wound healing process. Korean J Anesthesiol. 2009;57(1):78-83. doi:10. 4097/kjae.2009.57.1.78
14. Khan J, Noboru N, Young A, Thomas D. Pro and anti-inflammatory cytokine levels (TNF-α, IL-1β, IL-6 and IL-10) in rat model of neuroma. Pathophysiology. 2017;24(3):155-159. doi:10.1016/j.pathophys.2017.04.001
15. Alzoghaibi MA, Al-Oraini AI, Al-Sagheir AI, Zubaidi AM. Temporal expression of IL-1β and IL-10 in rat skin, muscle, small bowel, and colon wounds: a correlative study. J Basic Clin Physiol Pharmacol. 2014;25(2):205-210. doi:10.1515/jbcpp-2013-0073
16. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991; 174(5):1209-1220. doi:10.1084/jem.174.5.1209
Volume 2, Issue 1, 2025
Page : 1-6
_Footer